[1] 广东省药品监管局. 广东省中药材标准化橘红胎(化橘红珠)[S]. 广州:广东省药品监督管理局,2021,3. [2] 国家卫生健康委员会,国家市场监督管理总局.关于地黄等4种按照传统既是食品又是中药材的物质的公告[EB/OL].(2024-08-26)[2025-11-01].http://www.nhc.gov.cn/sps/s7890/202408/01f4b82eff294f4182102cf43e2e898e.shtml. [3] 曹晖,赵维良,郝近大,等. 中国药典2020年版药材基原拉丁学名考证[J]. 中药材,2022,45(4): 989-994. [4] 吴孟华,钟楚楚,余品皓,等. 橘红与化橘红的古今演变探析[J]. 中国中药杂志,2021,46(3): 736-744. [5] 何克谏. 《增补食物本草备考》校注与研究[M]. 北京: 人民卫生出版社,2016. [6] 国家食品安全风险评估中心. 食品安全风险评估技术程序与应用指南[M]. 北京: 中国质量标准出版传媒有限公司,2022. [7] Li PB, Wang S, Guan XL, et al.Acute and 13 weeks subchronic toxicological evaluation of naringin in Sprague-Dawley rats[J]. Food Chem Toxicol, 2013, 60: 1-9. [8] Tian F, He XF, Sun J, et al.Simultaneous quantitative analysis of nine constituents in six Chinese medicinal materials from Citrus genus by high-performance liquid chromatography and high-resolution mass spectrometry combined with chemometric methods[J]. J Sep Sci, 2020, 43(4): 736-747. [9] Li PB, Wang S, Guan XL, et al.Six months chronic toxicological evaluation of naringin in Sprague-Dawley rats[J]. Food Chem Toxicol, 2014, 66: 65-75. [10] Wang YG, Wu H, Chen P, et al.Fertility and early embryonic development toxicity assessment of naringin in Sprague-Dawley rats[J]. Regul Toxicol Pharmacol, 2021, 123: 104938. [11] Liu D, Wu J, Xie HB, et al.Inhibitory effect of hesperetin and naringenin on human UDP-glucuronosyltransferase enzymes: Implications for herb-drug interactions[J]. Biol Pharm Bull, 2016, 39(12): 2052-2059. [12] Briguglio M, Hrelia S, Malaguti M, et al.Food bioactive compounds and their interference in drug pharmacokinetic/pharmacodynamic profiles[J]. Pharmaceutics, 2018, 10(4): 277. [13] 吕锦涛,张丹,张冰,等. 柑橘属中药的药物相互作用研究进展[J]. 中国药物警戒,2021,18(4):495-498,500. [14] Cox D, O'Kennedy R, Thornes RD. The rarity of liver toxicity in patients treated with coumarin (1, 2-benzopyrone)[J]. Hum Toxicol, 1989, 8(6): 501-506. [15] 郭鹏杰,林志健,张晓朦,等. 香豆素类化合物毒理研究及安全性思考[J]. 中国中药杂志,2020,45(3):518-522. |